Quart Barry D
Director at KNSA; Chief Executive Officer at HRTX; Director at TRIMERIS INC, and 1 more
- Sold, on record
- $15.8M
- Dollars the filings state
- Form 4 sales
- 23
- Latest Apr 28, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- KNSAKiniksa Pharmaceuticals International, plcDirector
- HRTXHERON THERAPEUTICS, INC. /DE/Chief Executive Officer
- TRIMERIS INCDirector
- INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- HRTX260,000 shares
- INTRABIOTICS PHARMACEUTICALS INC /DE205,000 shares
- KNSA108,296 shares
- TRIMERIS INC3,375 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale HRTXUnusualJun 21 2018
Sold 50,000 shares at $39.05 ($2M)
Quart Barry D, Chief Executive Officer
Sold 41.8% of holdings ($4.7M position)69,600 shares leftFiling
- 2 Form 4 sale KNSAUnusualNov 29 +1622 days
Sold 21,959 shares at $16.15 ($355k)
Quart Barry D, Director
Sold 100% of holdings ($355k position)0 shares leftFirst sale on recordFiling
- 3 Form 4 sale KNSAUnusualJun 11 +925 days
Sold 27,448 shares at $30.35 ($833k)
Quart Barry D, Director
No 10b5-1 planSold 68.6% of holdings ($1.2M position)12,546 shares leftFirst sale on recordFiling
- 4 Form 4 sale KNSARoutineDec 15 +187 days
Sold 20,129 shares at $41.51 ($836k)
Quart Barry D, Director
10b5-1 planSold 61.6% of holdings ($1.4M position)12,546 shares leftFiling
- 5 Form 4 sale KNSARoutineFeb 4 +51 days
Sold 15,960 shares at $45.22 ($722k)
Quart Barry D, Director
10b5-1 planSold 56% of holdings ($1.3M position)12,546 shares leftFiling
- 6 Form 4 sale KNSARoutineFeb 12 +8 days
Sold 2,800 shares at $45.00 ($126k)
Quart Barry D, Director
10b5-1 planSold 18.2% of holdings ($691k position)12,546 shares left0.1x usual sizeFiling
- 7 Form 4 sale KNSARoutineApr 6 +53 days
Sold 6,901 shares at $50.00 ($345k)
Quart Barry D, Director
10b5-1 planSold 35.5% of holdings ($972k position)12,546 shares left0.4x usual sizeFiling
- 8 Form 4 sale KNSARoutineApr 28 +22 days
Sold 13,099 shares at $50.10 ($656k)
Quart Barry D, Director
10b5-1 planSold 51.1% of holdings ($1.3M position)12,546 shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (23)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | KNSA | Director | Form 4 sale | 13,099 | $656k | 51.1% | Routine | SEC |
| Apr 6, 2026 | KNSA | Director | Form 4 sale | 6,901 | $345k | 35.5% | Routine | SEC |
| Feb 12, 2026 | KNSA | Director | Form 4 sale | 2,800 | $126k | 18.2% | Routine | SEC |
| Feb 4, 2026 | KNSA | Director | Form 4 sale | 15,960 | $722k | 56.0% | Routine | SEC |
| Dec 15, 2025 | KNSA | Director | Form 4 sale | 20,129 | $836k | 61.6% | Routine | SEC |
| Jun 11, 2025 | KNSA | Director | Form 4 sale | 27,448 | $833k | 68.6% | Unusual | SEC |
| Nov 29, 2022 | KNSA | Director | Form 4 sale | 21,959 | $355k | 100.0% | Unusual | SEC |
| Jun 21, 2018 | HRTX | Chief Executive Officer | Form 4 sale | 50,000 | $2M | 41.8% | Unusual | SEC |
| Mar 19, 2018 | HRTX | Chief Executive Officer | Form 4 sale | 100,000 | $3M | 59.5% | Unusual | SEC |
| Mar 14, 2018 | HRTX | Chief Executive Officer | Form 4 sale | 100,000 | $2.5M | 59.5% | Unusual | SEC |
| Mar 2, 2015 | HRTX | Chief Executive Officer | Form 4 sale | 10,000 | $131k | 18.9% | Plan not stated | SEC |
| Jun 20, 2014 | TRIMERIS INC | Director | Form 4 sale | 1,375 | $138k | 100.0% | Unusual | SEC |
| Jun 17, 2014 | TRIMERIS INC | Director | Form 4 sale | 1,000 | $90k | 100.0% | Unusual | SEC |
| Jun 12, 2014 | TRIMERIS INC | Director | Form 4 sale | 1,000 | $83k | 100.0% | Unusual | SEC |
| May 9, 2011 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 20,000 | $544k | 24.3% | Plan not stated | SEC |
| Feb 7, 2011 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 20,000 | $535k | 29.8% | Unusual | SEC |
| Dec 8, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 20,000 | $438k | 35.0% | Unusual | SEC |
| Aug 9, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 20,000 | $404k | 32.3% | Unusual | SEC |
| May 7, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 25,000 | $530k | 37.6% | Unusual | SEC |
| Feb 8, 2010 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 25,000 | $364k | 53.7% | Unusual | SEC |
| Dec 9, 2009 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 25,000 | $362k | 40.3% | Unusual | SEC |
| Aug 11, 2009 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 25,000 | $483k | 60.2% | Unusual | SEC |
| May 19, 2009 | INTRABIOTICS PHARMACEUTICALS INC /DE | President and CEO | Form 4 sale | 25,000 | $385k | 48.5% | Unusual | SEC |